封面
市场调查报告书
商品编码
1424343

血小板浓缩系统市场:按技术、按应用、按最终用户、按地区

Platelet Concentration Systems Market, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血小板浓缩系统的全球市场规模预计将从 2023 年的 4.249 亿美元增加到 2030 年的 8.384 亿美元,预测期内复合年增长率为 10.2%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 4.249 亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率: 10.20% 2030/2031 年预测值 8.384 亿美元
图 1. 2023 年按地区分類的血小板浓缩系统的全球市场占有率(%)
血小板浓缩系统市场-IMG1

血小板浓缩系统是用于浓缩从捐赠者血液中提取的血小板的重要医疗设备。从这些系统获得的富含血小板的血浆(PRP)含有比正常血液更高密度的血小板。 PRP 被定义为血小板浓度高于正常血浆的血浆,是透过自体血液的离心或重力过滤产生的。 PRP 广泛用于各种再生医学应用,包括治疗肌肉、骨骼和关节损伤的整形外科手术。该系统采用先进技术,透过离心将血小板与其他血液成分精确分离,然后小心地将其压缩成浓缩製剂。提供安全且临床有效量的自体 PRP,以增强身体的自然癒合能力。随着世界人口老化和运动伤害的增加,对微创血小板浓缩技术的需求不断增加。

市场动态:

全球血小板富集系统市场受到慢性病、运动伤害和创伤发生率上升的推动,这些疾病从 PRP 治疗中受益匪浅。在重组手术中越来越多地采用组织工程方法,以及在伤口护理中越来越依赖血液产品正在推动市场成长。然而,这些设备的高昂成本以及某些地区缺乏基于 PRP 的治疗的报销政策阻碍了普及。此外,每个系统都需要监管部门的批准,这给市场进入者带来了挑战。尚未开发的机会存在于拥有大量老年人口的新兴经济体以及将浓缩血小板用于新的医疗应用。为提高富集精度、製程自动化和适应症扩展而进行的持续研究和开发预计将在预测期内产生良好的前景。

本研究的主要特点

  • 该报告详细分析了全球血小板浓缩系统市场,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个细分市场的潜在收益成长机会,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球血小板浓缩系统市场的主要参与者进行了分析。
  • 本研究涵盖的主要企业包括 Anthrax Inc.、Stryker Corporation、Johnson &Johnson's、Zimmer Biomet Holdings Inc.、Terumo Corporation、Arteri Bathroom Systems, Inc.、Exactech Inc.、Harvest Technologies Corp. 和 Nuo Therapeutics, Inc.。Haemonetics Corporation 、Fresenius SE &Co.KGaA、Macopharma、BioIVT、Stago、Pall Corporation。
  • 该报告的见解将帮助行销人员和经营团队就未来的产品发布、类型升级、市场扩张和行销策略负责人明智的决策。
  • 全球血小板浓缩系统市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球血小板浓缩系统市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球血小板浓缩系统市场-冠状冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球血小板浓缩系统市场(按技术)2023-2030 年

  • 单采技术
  • 单自旋技术
  • 双旋技术

第六章全球血小板浓缩系统市场,依应用分类,2023-2030

  • 整形外科
  • 美容外科和皮肤科
  • 神经病学
  • 心臟病学
  • 其他(眼科/其他)

第 7 章 全球血小板浓缩系统市场,依最终使用者划分,2023-2030 年

  • 医院
  • 血库和输血中心
  • 门诊手术中心
  • 其他(研究实验室、独立加工设施)

第八章全球血小板浓缩系统市场,按地区,2023-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 竞争形势

  • Anthrax Inc.
  • Stryker Corporation
  • Johnson & Johnson's
  • Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Arteriocyte Medical Systems, Inc.
  • Exactech Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc.
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Macopharma
  • BioIVT
  • Stago
  • Pall Corporation

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4324

The Global Platelet Concentration Systems Market size is expected to reach US$ 838.4 Mn by 2030, from US$ 424.9 Mn in 2023, at a CAGR of 10.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 424.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 10.20% 2030/2031 Value Projection: US$ 838.4 Mn
Figure 1. Global Platelet Concentration Systems Market Share (%), by Region, 2023
Platelet Concentration Systems Market - IMG1

Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as plasma with an elevated platelet concentration over that of normal plasma and can be created using centrifugation or gravity filtration of autologous blood. PRP is being extensively used in various regenerative medicine applications such as orthopedic surgeries for treating muscle, bone and joint injuries. The systems are equipped with advanced technologies that precisely separate platelets from other blood components through centrifugation followed by their careful compression into a concentrated formulation. They deliver safe and clinically effective volumes of autologous PRP which boost the body's natural healing abilities. With the aging global population and rise in sports injuries, the demand for less invasive platelet concentration techniques is augmenting.

Market Dynamics:

The global platelet concentration systems market is driven by the rising incidence of chronic diseases, sports injuries, and trauma cases that considerably benefit from PRP therapies. The growing adoption of tissue engineering approaches in reconstructive procedures and an increasing dependence on blood-derived products for wound care are fueling the market growth. However, high costs associated with these devices and lack of reimbursement policies for PRP-based treatments in some regions can impede widespread adoption. Moreover, each system requiring regulatory clearances poses challenges for market players. The untapped opportunities lie in developing economies with large geriatric populations and in utilizing platelet concentrate for new medical applications. Ongoing R&D for improving concentration accuracy, automating the process and expanding indications are expected to create lucrative prospects over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global platelet concentration systems market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global platelet concentration systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Macopharma, BioIVT, Stago, and Pall Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global platelet concentration systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet concentration systems market

Platelet Concentration Systems Market Detailed Segmentation:

  • By Technology
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • By Application
    • Orthopedics
    • Cosmetic Surgery and Dermatology
    • Neurology
    • Cardiology
    • Others (Ophthalmology and Others)
  • By End User
    • Hospital
    • Blood Banks and Transfusion Centers
    • Ambulatory Surgical Centers
    • Others (Research Laboratories, Stand-alone Processing Facilities)
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Platelet Concentration Systems Market
    • Anthrax Inc.
    • Stryker Corporation
    • Johnson & Johnson's
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Arteriocyte Medical Systems, Inc.
    • Exactech Inc.
    • Harvest Technologies Corp.
    • Nuo Therapeutics, Inc.
    • Haemonetics Corporation
    • Fresenius SE & Co. KGaA
    • Macopharma
    • BioIVT
    • Stago
    • Pall Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Platelet Concentration Systems Market, By Technology
    • Global Platelet Concentration Systems Market, By Application
    • Global Platelet Concentration Systems Market, By End User
    • Global Platelet Concentration Systems Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Platelet Concentration Systems Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Platelet Concentration Systems Market, By Technology, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Apheresis Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Single Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Double Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Global Platelet Concentration Systems Market, By Application, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Cosmetic Surgery and Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Others (Ophthalmology and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Global Platelet Concentration Systems Market, By End User, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Blood Banks and Transfusion Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Others (Research Laboratories, Stand-alone Processing Facilities)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

8. Global Platelet Concentration Systems Market, By Region, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country, 2018 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2023-2030,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Anthrax Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson's
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Arteriocyte Medical Systems, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Exactech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Harvest Technologies Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nuo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Haemonetics Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fresenius SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Macopharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioIVT
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Stago
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pall Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us